Immunochromatography Lateral Flow Strip Enhancement Based on Passive Gold Nanoparticles Conjugation to Detect Schistosma haematobium Antigens in Human Serum

El-Shall, Mahmoud N.
DOI: https://doi.org/10.1007/s11686-024-00841-y
2024-05-17
Acta Parasitologica
Abstract:This study aimed to develop and evaluate a lateral flow card for the detection of active Schistosoma haematobium infection.
parasitology,zoology,veterinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop and evaluate an immunochromatographic lateral - flow strip (ICLFS) for detecting active **Schistosoma haematobium** infections. Specifically, the study aims to improve the sensitivity and specificity of detecting schistosome antigens by passively binding antibodies to gold nanoparticles (AuNPs), thereby achieving early, rapid, and accurate diagnosis. ### Research Background Schistosomiasis is a disease caused by parasites, mainly affecting residents in Africa and the Middle East. According to data from the World Health Organization (WHO), approximately 251.4 million people worldwide are affected by schistosomiasis, and 90% of those in need of treatment are concentrated in Africa. Schistosomiasis can not only lead to urinary system diseases, such as cystitis and dysuria, but may also cause more serious health problems, such as bladder cancer or kidney failure. Traditional diagnostic methods, such as microscopic examination, are simple and low - cost, but their sensitivity is low, making it difficult to detect early or mild infections, resulting in inaccurate diagnosis. Therefore, developing a highly sensitive and highly specific diagnostic tool is crucial for controlling and preventing the spread of schistosomiasis. ### Research Objectives The main objective of this study is to develop an immunochromatographic lateral - flow strip (ICLFS) based on the passive binding of gold nanoparticles to improve the ability to detect **S. haematobium** antigens, especially in human serum samples. By improving the diagnostic tool, researchers hope to more accurately identify infections at an early stage, thereby improving treatment effectiveness and reducing the spread of the disease. ### Main Results - **Sensitivity and Specificity**: The new ICLFS correctly identified 64 out of 67 schistosome - positive samples, with a sensitivity of 95.5% and a specificity of 93.3%. In comparison, the sensitivity of the sandwich ELISA using gold nanoparticle binding was 91.1% and the specificity was 88.8%. - **Predictive Values**: The negative predictive value (NPV) of ICLFS was 90% and the positive predictive value (PPV) was 91.4%, both better than those of the sandwich ELISA. - **Advantages**: ICLFS has higher sensitivity and specificity, can detect infections earlier and faster, and is especially suitable for areas with limited resources. In addition, this method does not require complex laboratory equipment and is easy to operate, making it suitable for large - scale screening. In conclusion, this study shows that ICLFS, as a new diagnostic tool, performs excellently in detecting **S. haematobium** infections, especially having obvious advantages in early diagnosis.